Author:
Edoka Ijeoma,Matsela Lineo Marie,Modiba Khumo,Luther Yolandie,Govender Sharlene,Maotoe Thapelo,Brahmbhatt Heena,Pisa Pedro T.,Meyer-Rath Gesine,Miot Jacqui
Abstract
Abstract
Background
The COVID-19 vaccination programme in South Africa was rolled out in February 2021 via five delivery channels- hospitals, primary healthcare (PHC), fixed, temporary, and mobile outreach channels. In this study, we estimated the financial and economic costs of the COVID-19 vaccination programme in the first year of roll out from February 2021 to January 2022 and one month prior, in one district of South Africa, the West Rand district.
Methods
Financial and economic costs were estimated from a public payer’s perspective using top-down and ingredient-based costing approaches. Data were collected on costs incurred at the national level and from the West Rand district. Total cost and cost per COVID-19 vaccine dose were estimated for each of the five delivery channels implemented in the district. In addition, we estimated vaccine delivery costs which we defined as total cost exclusive of vaccine procurement costs.
Results
Total financial and economic costs were estimated at US$8.5 million and US$12 million, respectively; with a corresponding cost per dose of US$15.31 (financial) and US$21.85 (economic). The two biggest total cost drivers were vaccine procurement which contributed 73% and 51% to total financial and economic costs respectively, and staff time which contributed 10% and 36% to total financial and economic costs, respectively. Total vaccine delivery costs were estimated at US$2.1 million (financial) and US$5.7 million (economic); and the corresponding cost per dose at US$3.84 (financial) and US$10.38 (economic). Vaccine delivery cost per dose (financial/economic) was estimated at US$2.93/12.84 and US$2.45/5.99 in hospitals and PHCs, respectively, and at US$7.34/20.29, US$3.96/11.89 and US$24.81/28.76 in fixed, temporary and mobile outreach sites, respectively. Staff time was the biggest economic cost driver for vaccine delivery in PHCs and hospitals while per diems and staff time were the biggest economic cost drivers for vaccine delivery in the three outreach delivery channels.
Conclusion
This study offers insights for budgeting and planning of COVID-19 vaccine delivery in South Africa’s public healthcare system. It also provides input for cost-effectiveness analyses to guide future strategies for maximizing vaccination coverage in the country.
Funder
Bill and Melinda Gates Foundation
United States Agency for International Development
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. NDoH. National Department of Health Annual Report 2021/22. Pretoria, South Africa: National Department of Health; 2022. Available from:
https://www.health.gov.za/wp-content/uploads/2022/10/2022-Annual-Report-Compressed.pdf.
2. Daniels RC, Casale D. The impact of COVID-19 in South Africa during the first year of the crisis: evidence from the NIDS-CRAM survey. Dev South Afr. 2022;39(5):605–22.
3. National Treasury. Estimates of National Expenditure- Health (Vote 18). Pretoria, South Africa: National Treasury; 2022. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.treasury.gov.za/documents/national%20budget/2022/ene/Vote%2018%20Health.pdf.
4. DGCIS. SA Covid-19 Vaccine Strategy & Rollout: Key Messages. Pretoria, South Africa: Department of Government Communication and Information System; 2021. Available from:
https://www.gov.za/sites/default/files/gcis_speech/20210112_SA%20COVID-19%20Vaccine%20Strategy%20Talking%20Points.pdf.
5. Liu Y, Procter SR, Pearson CAB, Montero AM, Torres-Rueda S, Asfaw E, et al. Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries. BMC Med. 2023;21(1):85.